Tidal Vision Bags $140 Million in Series B Funding to Scale its Biotech Solutions Globally
Tidal Vision, a biotechnology company transforming critical industries with chitosan-based chemistries, announced the closing of an oversubscribed $140 million Series B financing round. The funding … Read more…